Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 197 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 08/08/18
End: 08/28/18
Due: 08/28/19
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 01/15/19
End: 08/24/20
Due: 08/24/21
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 04/20/20
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 01/13/12
End: 03/23/20
Due: 03/23/21
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 06/30/19
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 08/31/06
Due: 08/31/07
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 12/14/20
End: 09/23/21
Due: 09/23/22
Phase: N/A
Priority: Normal
Start: 12/08/20
End: 08/11/21
Due: 08/11/22
Phase: N/A
Priority: Normal
Start: 01/31/01
End: 06/30/05
Due: 06/30/06
Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
Phase: N/A
Priority: Normal
Start: 05/24/24
End: 05/31/28
Due: 05/31/29
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 09/30/17
Due: 09/30/18